Catherine Greenwood

Catherine Greenwood is a highly experienced Senior Scientist with a background in assay development and analytical research within the biotechnology and pharmaceutical sectors. Currently employed at DNA Electronics (DNAe) since May 2024, Catherine has previously held senior scientific roles at Gyroscope Therapeutics, Fluidic Analytics, Cambridge Epigenetix, and TwistDx, starting from September 2010. Catherine's work has included the development of assays for human influenza virus and applications in blood coagulation and haemostasis using a proprietary piezoelectric quartz crystal microbalance biosensor platform. Catherine holds a Bachelor of Science in Biochemistry from King's College London.